Scil Technology Receives Renewal of GMP Certification for its analytical and Bioassay Laboratories

MARTINSRIED, Germany

, December 09, 2004 - 

Scil Technology, a biopharmaceutical company focused on the development of dental and orthopaedic tissue regeneration products, today announced that it has received notification of a renewal of its GMP certification from the German health authorities.

Scil Technology has received the renewed license for the analytical and Bioassay Laboratories of the Pharmaceutical Quality unit. The basis for this includes both Scil Technology’s development activities in the area of tissue regeneration products and the Scil Biopharma Services service provision for major partners in the field of CMC development of  new biotechnological and biosimilar products.

Dr Irina Staatz-Granzer, Managing Director of Scil Technology, commented:
“Scil Technology has the highest standards of laboratory practice in accordance with GMP and WHO rules and we plan to continue this record of excellence in our future development efforts.”

About Scil Technology GmbH

Scil Technology is a private biopharmaceutical development company focused on dental and orthopaedic tissue regeneration with a particular emphasis on bone and cartilage repair. The Company’s lead therapeutic candidates are based on recombinant, highly specific human growth factors. These are combined with biodegradable biomaterials to generate local application forms. Scil Technology’s pipeline for dentistry includes products that are targeted at periodontal disease, dental implantology and maxillofacial surgery. Orthopaedic products are developed for spinal fusion, traumatic lesions of  bone and cartilage tissue  and osteoarthritis. Scil Technology has emerged from the Scil Group and is located in the biotechnology cluster in Martinsried, Germany.

For more information please visit: http://www.scil.com

Contacts

Media relations:

Sue Charles, MA, MBA, CEO
Northbank Communications
t : +44 (0) 20 7886 8152
e: s.charles@northbankcommunications.com

Douglas Pretsell, Ph.D., Senior Account Manager
Northbank Communications
t : +44 (0) 20 7886 8158
e:  d.pretsell@northbankcommunications.com

At Scil Technology:

Dr Irina Staatz-Granzer, Managing Director
Scil Technology GmbH
t: +49 (0)89 85651824
e: irina.staatz@scil.com